A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity
Abstract Background Bispecific antibody has garnered considerable attention in the recent years due to its impressive preliminary efficacy in hematological malignancies. For solid tumors, however, the main hindrance is the suppressive tumor microenvironment, which effectively impedes the activation...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMC
2023-05-01
|
| Cyfres: | Journal of Translational Medicine |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1186/s12967-023-04193-5 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|